Profitability improved sharply, but diagnostics growth and 4K Score reimbursement remain delayed while pipeline catalysts are largely future-dated [20] [116].
| Quarter | Q2 FY26 |
|---|---|
| Call date | 2026-07-27 |
| Length | 51 minutes |
| EPS | $-0.01 |
| Revenue | $163.6M |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
All OPK earnings ยท Back to OPK overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.